These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11805722)

  • 1. Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus.
    Kahan BD
    Ther Drug Monit; 2002 Feb; 24(1):47-52. PubMed ID: 11805722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720: A new kid on the block for transplant immunosuppression.
    Aki FT; Kahan BD
    Expert Opin Biol Ther; 2003 Jul; 3(4):665-81. PubMed ID: 12831371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of a new immunosuppressive agent, FTY720.
    Troncoso P; Kahan BD
    Clin Biochem; 1998 Jul; 31(5):369-73. PubMed ID: 9721436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.
    Gallo AP; Silva LB; Franco M; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1919-24. PubMed ID: 17219691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
    Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
    Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical results of sirolimus treatment in transplant models.
    Stepkowski SM
    Transplant Proc; 2003 May; 35(3 Suppl):219S-226S. PubMed ID: 12742499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
    Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
    Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
    Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
    [No Abstract]   [Full Text] [Related]  

  • 11. Sirolimus in combination with FTY720: analysis of urinary and serum parameters.
    Lopes CT; Pletiskaitz TM; de Franco MF; Cordeiro JA; Bueno V
    Transplant Proc; 2010 Mar; 42(2):582-4. PubMed ID: 20304197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720: a new immunosuppressive agent with novel mechanism(s) of action.
    Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2210-3. PubMed ID: 9723444
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus and FTY720: new approaches to transplant immunosuppression.
    Kahan BD
    Transplant Proc; 2002 Nov; 34(7):2520-2. PubMed ID: 12431509
    [No Abstract]   [Full Text] [Related]  

  • 16. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future immunosuppressive agents in solid-organ transplantation.
    Gabardi S; Cerio J
    Prog Transplant; 2004 Jun; 14(2):148-56. PubMed ID: 15264459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 immunomodulation: optimism for improved transplant regimens.
    Ferguson R
    Transplant Proc; 2004 Mar; 36(2 Suppl):549S-553S. PubMed ID: 15041404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
    Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New immunosuppresor strategies in the treatment of murine lupus nephritis.
    Alperovich G; Rama I; Lloberas N; Franquesa M; Poveda R; Gomà M; Herrero-Fresneda I; Cruzado JM; Bolaños N; Carrera M; Grinyó JM; Torras J
    Lupus; 2007; 16(1):18-24. PubMed ID: 17283580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.